<code id='AD592CE288'></code><style id='AD592CE288'></style>
    • <acronym id='AD592CE288'></acronym>
      <center id='AD592CE288'><center id='AD592CE288'><tfoot id='AD592CE288'></tfoot></center><abbr id='AD592CE288'><dir id='AD592CE288'><tfoot id='AD592CE288'></tfoot><noframes id='AD592CE288'>

    • <optgroup id='AD592CE288'><strike id='AD592CE288'><sup id='AD592CE288'></sup></strike><code id='AD592CE288'></code></optgroup>
        1. <b id='AD592CE288'><label id='AD592CE288'><select id='AD592CE288'><dt id='AD592CE288'><span id='AD592CE288'></span></dt></select></label></b><u id='AD592CE288'></u>
          <i id='AD592CE288'><strike id='AD592CE288'><tt id='AD592CE288'><pre id='AD592CE288'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:41393
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          Google's generative AI to analyze medical images — and talk to docs
          Google's generative AI to analyze medical images — and talk to docs

          NOAHSEELAM/AFPviaGettyImagesGoogle’sgenerativeAIsystemproveditcananswermedicalexamquestions.Butnowth

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Many breast cancer patients receive more radiation than needed

          KathiKolb,aRhodeIslandphysicaltherapist,saysshe’sfrustratedthatfewerthanhalfofeligiblebreastcancerpa